Hallucination

DefinitionNLM MeSH D006212

Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.

Source: U.S. National Library of Medicine — MeSH (Hallucinations)

Drugs reporting Hallucination (59)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1. 1Triethanolamine150%
2. 2Pimavanserin12,12223%
3. 3Afamitresgene Autoleucel117%
4. 4Dichromate Ion117%
5. 5Mavorixafor117%
6. 6Cobamamide114%
7. 7Ferrous Cysteine Glycinate114%
8. 8Magnesium Ascorbate114%
9. 9Nadh114%
10. 10Pyridoxal114%
11. 11Threonate114%
12. 12Zinc Ascorbate114%
13. 13Opicapone29514%
14. 14Entacapone53012%
15. 15Safinamide14512%
16. 16Istradefylline60310%
17. 17Carbidopa4,4528.6%
18. 18Rasagiline9288.5%
19. 19Levodopa4,7048.0%
20. 20Tolcapone277.9%
21. 21Gentian Violet47.8%
22. 22Mefloquine127.8%
23. 23Phenoxybenzamine27.7%
24. 24Amantadine1,5087.6%
25. 25Rivastigmine1,4307.6%
26. 26Ziconotide1666.8%
27. 27Selegiline2276.5%
28. 28Zanamivir1596.3%
29. 29Apomorphine915.4%
30. 30Lorlatinib3525.4%
31. 31Pramipexole9695.1%
32. 32Rotigotine7115.1%
33. 33Cysteine75.0%
34. 34Ropinirole8694.8%
35. 35Memantine6434.7%
36. 36Donepezil1,5674.3%
37. 37Difelikefalin164.1%
38. 38Malathion44.1%
39. 39Lasmiditan443.9%
40. 40Pimozide183.9%
41. 41Ertapenem2633.7%
42. 42Oseltamivir8743.6%
43. 43Galantamine1143.6%
44. 44Proguanil763.6%
45. 45Adenine23.6%
46. 46Linvoseltamab13.6%
47. 47Nogapendekin Alfa Inbakicept13.4%
48. 48Daridorexant723.0%
49. 49Trihexyphenidyl283.0%
50. 50Suvorexant3732.9%
51. 51Tartrate15,9822.8%
52. 52Voriconazole6902.3%
53. 53Aripiprazole Lauroxil1022.3%
54. 54Mebendazole172.2%
55. 55Vilazodone1942.1%
56. 56Levorphanol71.9%
57. 57Esketamine2781.7%
58. 58Baloxavir301.3%
59. 59Baloxavir Marboxil301.3%

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

• Parkinson^s Disease14 shared · 0.23
• Dyskinesia14 shared · 0.17
• Abnormal Dreams11 shared · 0.17
• Cognitive Disorder10 shared · 0.13
• Tremor20 shared · 0.13
• Confusional State23 shared · 0.12
• Anxiety Disorder7 shared · 0.12
• Catheter Site Irritation7 shared · 0.12
• Foot Operation7 shared · 0.12
• Infusion Site Urticaria7 shared · 0.12

Literature

Recent PubMed references pinned to Hallucinations as a MeSH major topic. About the reaction term itself — not about any specific drug.

• Phenomenology of Subjective Anomalous Experiences in People with Schizophrenia.
  Culture, medicine and psychiatry · 2026 · Mondragón-Benítez O, Díaz-Castro L, Corona-Hernández F, et al.
  PMID 42176079DOI 10.1007/s11013-026-09989-w
• Combining Anti-Hallucination Strategies for Reliable LLM-Based Clinical Information Extraction.
  Studies in health technology and informatics · 2026 · Yapo J, Dong C, Cuggia M, et al.
  PMID 42175025DOI 10.3233/SHTI260351
• 'Everywhere I turn, I'm blocked': a qualitative exploration of experiences of Charles Bonnet syndrome and its impact on physical activity and falls.
  Age and ageing · 2026 · Fisher K, Sanders C, Jolly JK, et al.
  PMID 42143601DOI 10.1093/ageing/afag125
• Rivastigmine for Behavioural Symptoms in Parkinson's Disease: Evidence and Open Questions.
  Human psychopharmacology · 2026 · Luca A
  PMID 42138429DOI 10.1002/hup.70049
• Impaired Self-Other Voice Discrimination in Patients with Auditory-Verbal Hallucinations and Nonclinical Hallucination Proneness.
  Schizophrenia bulletin · 2026 · Vukojević J, Jelić L, McCormack K, et al.
  PMID 42132926DOI 10.1093/schbul/sbag073
• [Historical approach to late visual hallucinations, from Charles Bonnet to Lewy body disease].
  Geriatrie et psychologie neuropsychiatrie du vieillissement · 2026 · Albou P
  PMID 42112641DOI 10.1684/pnv.2026.1273